Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia

J Pediatr. 2012 Feb;160(2):286-90. doi: 10.1016/j.jpeds.2011.07.018. Epub 2011 Sep 3.

Abstract

Objective: To identify factors associated with frequent severe vaso-occlusive pain crises in a contemporary pediatric cohort of patients with sickle cell anemia (SCA) enrolled in a prospective study of pulmonary hypertension and the hypoxic response in sickle cell disease.

Study design: Clinical and laboratory characteristics of children with SCA who had ≥3 severe pain crises requiring health care in the preceding year were compared with those of subjects with <3 such episodes.

Results: Seventy-five children (20%) reported ≥3 severe pain episodes in the preceding year, and 232 (61%) had none. Frequent pain episodes were associated with older age (OR, 1.2; 95% CI, 1.1-1.3; P < .0001), α-thalassemia trait (OR 3.5; 1.6-6.7; P = .002), higher median hemoglobin (OR 1.7; 95% CI: 1.2-2.4; P < .003), and lower lactate dehydrogenase concentration (OR 1.82; 95% CI: 1.07-3.11; P = .027). Children with high pain frequency also had an increased iron burden (serum ferritin, 480 vs 198 μg/L; P = .006) and higher median tricuspid regurgitation jet velocity (2.41 vs 2.31 m/s; P = .001). Neither hydroxyurea use nor fetal hemoglobin levels were significantly different according to severe pain history.

Conclusions: In our cohort of children with SCA, increasing age was associated with higher frequency of severe pain episodes as were α-thalassemia, iron overload, higher hemoglobin and lower lactate dehydrogenase concentration, and higher tricuspid regurgitation velocity.

Trial registration: ClinicalTrials.gov NCT00495638.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural

MeSH terms

  • Acute Disease
  • Adolescent
  • Age Factors
  • Anemia, Sickle Cell / blood
  • Anemia, Sickle Cell / complications*
  • Anemia, Sickle Cell / physiopathology
  • Biomarkers
  • Child
  • Female
  • Hemoglobins / metabolism
  • Humans
  • In Vitro Techniques
  • Iron Overload / physiopathology
  • L-Lactate Dehydrogenase / blood
  • Male
  • Pain / blood
  • Pain / diagnosis*
  • Pain / etiology*
  • Pain / physiopathology
  • Prospective Studies
  • Risk Factors
  • Severity of Illness Index
  • Tricuspid Valve Insufficiency / etiology
  • Tricuspid Valve Insufficiency / physiopathology
  • Vascular Diseases / blood
  • Vascular Diseases / diagnosis*
  • Vascular Diseases / etiology*
  • Vascular Diseases / physiopathology
  • alpha-Thalassemia / physiopathology

Substances

  • Biomarkers
  • Hemoglobins
  • L-Lactate Dehydrogenase

Associated data

  • ClinicalTrials.gov/NCT00495638